XML 114 R93.htm IDEA: XBRL DOCUMENT v3.24.2
Shareholders' Equity - Summary of Awards Granted to Non-employee Directors (Details) - Non-employee Directors - $ / shares
12 Months Ended
Apr. 27, 2024
Apr. 29, 2023
Apr. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested Outstanding beginning balance (in shares) 45,750 17,956 0
Awarded (in shares) 48,373 43,334 32,731
Issued (in shares) (16,804) (15,540) (14,775)
Non-vested Outstanding ending balance (in shares) 77,319 45,750 17,956
Weighted average grant date fair value      
Weighted average grant date fair value - beginning balance (in dollars per share) $ 40.56 $ 47.35 $ 0
Weighted average grant date fair value, awarded (in dollars per share) 32.72 36.13 47.37
Weighted average grant date fair value, issued (in dollars per share) 33.33 36.04 47.39
Weighted average grant date fair value - ending balance (in dollars per share) $ 37.23 $ 40.56 $ 47.35
Non-Employee Director Awards      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested Outstanding beginning balance (in shares) 0 0 0
Awarded (in shares) 16,804 15,540 14,775
Issued (in shares) (16,804) (15,540) (14,775)
Non-vested Outstanding ending balance (in shares) 0 0 0
Deferred Non-Employee Director Awards      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested Outstanding beginning balance (in shares) 45,750 17,956 0
Awarded (in shares) 31,569 27,794 17,956
Issued (in shares) 0 0 0
Non-vested Outstanding ending balance (in shares) 77,319 45,750 17,956